Gene: Cbs
Official Full Name: cystathionine beta-synthaseprovided by MGI
Gene Summary: Enables cystathionine beta-synthase activity. Acts upstream of or within several processes, including endochondral bone morphogenesis; regulation of intracellular signal transduction; and sulfur amino acid metabolic process. Predicted to be located in nucleus. Predicted to be active in cytoplasm. Is expressed in several structures, including alimentary system; connective tissue; nervous system; sensory organ; and skeleton. Used to study homocystinuria and hyperhomocysteinemia. Human ortholog(s) of this gene implicated in several diseases, including cerebral infarction; homocystinuria; hyperhomocysteinemia; malaria; and neural tube defect. Orthologous to human CBS (cystathionine beta-synthase). [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01099 | Cbs Knockout cell line (HT22) | Mouse | Cbs | 1:3-1:5 | Negative | Online Inquiry |
Cbs Gene Knockout Cell Lines are specialized cellular models engineered to lack the expression of the cystathionine beta-synthase (Cbs) gene, which plays a crucial role in the transsulfuration pathway, converting homocysteine to cystathionine. These cell lines serve as invaluable tools for researchers investigating the metabolic pathways associated with sulfur amino acids, contributing to the understanding of their implications in various biological processes and diseases.
The primary functions of Cbs Gene Knockout Cell Lines stem from their altered metabolic framework, which enables scientists to study the physiological consequences of Cbs deficiency. The knockout of the Cbs gene leads to increased levels of homocysteine and deficits in cysteine production, providing insights into the metabolic dysregulation associated with hyperhomocysteinemia—a condition linked to cardiovascular diseases and neurological disorders. By employing these cell lines, researchers can explore the downstream effects of altered metabolic states, drug interactions, and therapeutic interventions.
In clinical and preclinical settings, the scientific importance of Cbs Gene Knockout Cell Lines is underscored by their application in drug discovery and disease modeling. They facilitate a deeper understanding of the mechanisms underlying cellular responses to stress, oxidative damage, and mitochondrial function. Researchers utilize these models to develop new therapeutic strategies and evaluate the efficacy of candidate drugs targeting metabolic disorders related to Cbs deficiency.
What sets Cbs Gene Knockout Cell Lines apart from conventional cell lines is their precision, created using advanced CRISPR/Cas9 genome editing technology, which allows for highly efficient and targeted gene disruption. This specificity translates to reliable and reproducible experimental outcomes, an essential factor when pursuing meaningful research results. Moreover, the availability of various genetic backgrounds provides flexibility and relevance in studies across different tissues and organisms.
The value of Cbs Gene Knockout Cell Lines is evident for researchers and clinicians focused on metabolic research and therapeutic advancements. They enable groundbreaking studies that can elucidate complex pathways and contribute to innovative solutions for human health challenges.
With a commitment to advancing biological research, our company excels in biotechnological innovations, offering meticulously developed cell models, including Cbs Gene Knockout Cell Lines, to support your research endeavors. Our expertise is reflected in the quality and reliability of our products, ensuring that researchers are equipped with the best tools for their scientific inquiries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.